Our companies are developing innovative therapeutics for severe diseases and contitions. We are backing great teams with development programs that make a true difference for patients.
AlentisTherapeutics discovers and develops novel mediacations to treat advanced liver diseases, such as liver fibrosis, cirrhosis and liver cancer (hepatocellular carcinoma, HCC).Website
AM-Pharma is a clinical stage biopharmaceutical company developing recombinant human Alkaline Phosphatase (recAP) as a potentially life-saving treatment of acute kidney injury and sepsis.Website
Corlieve Therapeutics is a French biotech company, developing transformational therapies for neurological diseases. The lead program is a treatment for drug resistant temporal lobe epilepsy leveraging innovative gene therapy approaches.Website